Thirunavukarasu S, Jex N, Chowdhary A, Ul Hassan I, et al. Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes. Diabetes 2021 Oct 5. pii: db21-0270. doi: 10.2337/db21-0270.
PMID: 34610982